Given the increase in hTh1 cells, which are widely considered the principal CD4+ T cell mediators of GVHD [54,87], these cells could be a contributing factor as to why mice treated with high-dose PTCy still succumb to the disease. Here, CD4 is linked to graft versus host disease.